The FDA’s expert panel backs COVID-19 booster shots for adults 65 and older and those at highest risk of severe disease Andrew Dunn,Hilary Brueck 17 sep 2021
3 lingering questions about COVID-19 vaccines will shape the pandemic’s trajectory into 2022 and beyond Andrew Dunn,Hilary Brueck 01 jun 2021
J&J’s one-dose coronavirus vaccine just won a critical thumbs-up from an FDA panel, paving the way for US authorization Andrew Dunn,Hilary Brueck 26 feb 2021
An influential expert panel just gave its blessing to Pfizer’s 2-dose coronavirus shot, teeing up the FDA to imminently authorize the US’ first COVID-19 vaccine Andrew Dunn,Hilary Brueck 10 dec 2020
